Guest guest Posted December 23, 2010 Report Share Posted December 23, 2010 Hi Beau, I'm sorry to hear of your recent diagnosis. I don't know of anyone personally that has developed myeloma after already having CML but there are a couple of papers published about such patients. http://tinyurl.com/27rbdgb http://tinyurl.com/2ferpjh http://tinyurl.com/27aoddz Tracey > > Hi all, > > I was diagnosed with CML back in 2000 and have been part of the 113 sti571 (Glivec/Gleevec) trial since january 2001. > > Today I was diagnosed with Myeloma, I am led to believe that this is a fairly rare occurrence, for someone to have CML and Myeloma at the same time. > > Novartis - the manufacturer's of Glivec/Gleevec - say that they have no statistical data related to people within the trial group who may have developed Myeloma. > > My question to the group is, does anyone have any knowledge of anyone who may have developed Myeloma in conjunction with CML while taking Glivec/Gleevec; or any other form of treatment? > > Any infornmation regarding this would be greatly appreciated. > > With regards > > Beau > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 23, 2010 Report Share Posted December 23, 2010 Hi Beau - The Multiple Myeloma Research Foundation might be able to assist you. Pat in Phoenix Multiple Myeloma Research Foundation (MMRF) 383 Main Avenue 5th Floor Norwalk, CT 06851 Phone: (203) 229-0464 Email: info@... Web: www.themmrf.org > > Hi all, > > I was diagnosed with CML back in 2000 and have been part of the 113 sti571 (Glivec/Gleevec) trial since january 2001. > > Today I was diagnosed with Myeloma, I am led to believe that this is a fairly rare occurrence, for someone to have CML and Myeloma at the same time. > > Novartis - the manufacturer's of Glivec/Gleevec - say that they have no statistical data related to people within the trial group who may have developed Myeloma. > > My question to the group is, does anyone have any knowledge of anyone who may have developed Myeloma in conjunction with CML while taking Glivec/Gleevec; or any other form of treatment? > > Any infornmation regarding this would be greatly appreciated. > > With regards > > Beau > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 23, 2010 Report Share Posted December 23, 2010 Hi Beau: I was diagnosed in 1998 with my CML, and I was in the Gleevec Trial in Oct. of 2000. I am still on Gleevec till this day, and I have not heard of anyone else getting Myeloma with the CML either. I will tell you that I do not take any of these new medications that they show commercials for on TV. They start listing what else you could get and they mention Lymphoma a lot. Hope you get some answers, and sorry to hear of your diagnosis. Will pray for good results for you. From: phoenixpat <phoenixpat@...> Subject: [ ] Re: CML and Myeloma Date: Thursday, December 23, 2010, 3:58 PM  Hi Beau - The Multiple Myeloma Research Foundation might be able to assist you. Pat in Phoenix Multiple Myeloma Research Foundation (MMRF) 383 Main Avenue 5th Floor Norwalk, CT 06851 Phone: (203) 229-0464 Email: info@... Web: www.themmrf.org > > Hi all, > > I was diagnosed with CML back in 2000 and have been part of the 113 sti571 (Glivec/Gleevec) trial since january 2001. > > Today I was diagnosed with Myeloma, I am led to believe that this is a fairly rare occurrence, for someone to have CML and Myeloma at the same time. > > Novartis - the manufacturer's of Glivec/Gleevec - say that they have no statistical data related to people within the trial group who may have developed Myeloma. > > My question to the group is, does anyone have any knowledge of anyone who may have developed Myeloma in conjunction with CML while taking Glivec/Gleevec; or any other form of treatment? > > Any infornmation regarding this would be greatly appreciated. > > With regards > > Beau > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 24, 2010 Report Share Posted December 24, 2010 Hi I have been on 600 Gleevec since 2005. I have had 3 premyeloma removed from right leg front chest left of n0se. the dermatologist said this were caused from sun exposure 20 years before I got CML.So if I did not catch any of this spots I to would have Myeloma. dx 12/23/05 ________________________________ From: beau48au <worlord@...> Sent: Thu, December 23, 2010 8:02:11 AM Subject: [ ] CML and Myeloma  Hi all, I was diagnosed with CML back in 2000 and have been part of the 113 sti571 (Glivec/Gleevec) trial since january 2001. Today I was diagnosed with Myeloma, I am led to believe that this is a fairly rare occurrence, for someone to have CML and Myeloma at the same time. Novartis - the manufacturer's of Glivec/Gleevec - say that they have no statistical data related to people within the trial group who may have developed Myeloma. My question to the group is, does anyone have any knowledge of anyone who may have developed Myeloma in conjunction with CML while taking Glivec/Gleevec; or any other form of treatment? Any infornmation regarding this would be greatly appreciated. With regards Beau Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 24, 2010 Report Share Posted December 24, 2010 Folks  How does myeloma compare to melanoma? I am not sure I have heard of skin Myeloma before.  Thanks & Merry Christmas From: phoenixpat <phoenixpat@...> Subject: [ ] Re: CML and Myeloma Date: Thursday, December 23, 2010, 3:58 PM  Hi Beau - The Multiple Myeloma Research Foundation might be able to assist you. Pat in Phoenix Multiple Myeloma Research Foundation (MMRF) 383 Main Avenue 5th Floor Norwalk, CT 06851 Phone: (203) 229-0464 Email: info@... Web: www.themmrf.org > > Hi all, > > I was diagnosed with CML back in 2000 and have been part of the 113 sti571 (Glivec/Gleevec) trial since january 2001. > > Today I was diagnosed with Myeloma, I am led to believe that this is a fairly rare occurrence, for someone to have CML and Myeloma at the same time. > > Novartis - the manufacturer's of Glivec/Gleevec - say that they have no statistical data related to people within the trial group who may have developed Myeloma. > > My question to the group is, does anyone have any knowledge of anyone who may have developed Myeloma in conjunction with CML while taking Glivec/Gleevec; or any other form of treatment? > > Any infornmation regarding this would be greatly appreciated. > > With regards > > Beau > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 24, 2010 Report Share Posted December 24, 2010 What is Myeloma? Are we talking abt melanoma? Sent via BlackBerry by AT & T [ ] CML and Myeloma  Hi all, I was diagnosed with CML back in 2000 and have been part of the 113 sti571 (Glivec/Gleevec) trial since january 2001. Today I was diagnosed with Myeloma, I am led to believe that this is a fairly rare occurrence, for someone to have CML and Myeloma at the same time. Novartis - the manufacturer's of Glivec/Gleevec - say that they have no statistical data related to people within the trial group who may have developed Myeloma. My question to the group is, does anyone have any knowledge of anyone who may have developed Myeloma in conjunction with CML while taking Glivec/Gleevec; or any other form of treatment? Any infornmation regarding this would be greatly appreciated. With regards Beau Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 24, 2010 Report Share Posted December 24, 2010 Disease Complications Treatment Clinical Trials Side Effects of Treatment Response to Treatment Get More Information Contact Us Understanding Myeloma About 20,180 Americans will be diagnosed with myeloma this year. It is estimated that approximately 69,598 people in the United States are living with or are in remission from myeloma. Myeloma is a cancer of the plasma cells, a type of white cell found in many tissues of the body, but primarily in the bone marrow. Plasma cells are part of the body's immune system. Normal plasma cells make antibodies, which help fight infection. Myeloma cells cannot help the body fight infection. As the myeloma cells grow in the marrow they crowd out the normal plasma cells. They also crowd out normal white cells, red cells and platelets. Most people with myeloma are age 50 or older. Americans of African descent are diagnosed with myeloma about twice as often as Americans of European descent. People of Asian and Hispanic descent have lower rates of myeloma than other groups. This is a hopeful time for myeloma patients. Progress towards a cure is under way. New myeloma drugs have been approved in the last few years and new treatments are being studied. Return to top Causes The exact cause of myeloma is not known. Myeloma starts with a change to a single cell called a B lymphocyte. Normally, some B lymphocytes develop into plasma cells, which produce proteins called " antibodies " that can attach to an infectious agent and predispose it to be killed or removed.  With myeloma, the B lymphocyte becomes a myeloma cell instead of a normal plasma cell. Researchers are studying myeloma to understand why this change occurs. There is no way to prevent myeloma. You cannot catch myeloma from someone who has it.  Return to top Signs and Symptoms In the early stage of myeloma some patients have no signs or symptoms. Often the first symptom of myeloma is bone pain caused by the effects of myeloma cells in the marrow. Most patients feel pain in their back or ribs, but it can occur in any bone. Patients may have anemia, tire more easily and feel weak. Fractures may occur as a result of the weakened bones. Patients may have recurrent infections because antibodies to invading viruses, bacteria or other disease agents are not made efficiently and not in adequate amounts. Return to top Finding a Myeloma Specialist Myeloma patients are treated by oncologists or hematologists. It is best to choose a doctor who specializes and has experience in treating myeloma. Or have your local cancer specialist work with a myeloma specialist. Myeloma specialists know about new tests and treatments for your disease. Ask your primary care doctor Contact your community cancer center Call your local medical society Reach out to doctor and health plan referral services Call LLS for a list of cancer centers or visit www.LLS.org and click on " Cancer Centers " Use online physician-finder resources, such as The American Medical Association's " DoctorFinder " or the American Society of Hematology's " Find a Hematologist "  Return to top Types of Myeloma Most myeloma patients (about 90 percent of cases) have disease that involves multiple sites in the body at the time of diagnosis. This is often called multiple myeloma. A mass of myeloma cells is called a " plasmacytoma. " A plasmacytoma can form in the bone, skin, muscle, lungs or any other part of the body. Some people have a single mass of myeloma cells outside the marrow, called an extramedullary plasmacytoma. Extramedullary means that the mass of myeloma cells is outside the marrow. Rarely, people diagnosed with myeloma have solitary myeloma. This means they have one area of myeloma in the body. Myeloma that progresses slowly is called smoldering or indolent myeloma. Sometimes patients with smoldering or indolent myeloma do not need treatment right away. In most cases, treatment is needed at some point. Return to top Diagnosis and Staging Doctors do tests to look for signs of myeloma. Bone marrow aspiration and bone marrow biopsy Blood tests (including complete blood counts) Urine tests Imaging tests X-rays (skeletal surveys) CT scans MRIs PET scans Bone marrow aspiration and biopsy may be done in the doctor's office or in a hospital. The marrow is looked at under a microscope to see if there are myeloma cells. Lab tests are done to see if a protein called M protein or M spike is in the patient's blood and urine. The amount of M protein is one way to estimate the stage of the myeloma. Another protein called light chains can be found in the myeloma patient's urine. This protein is also called Bence protein.  Co-Pay Assistance Program support up to $10,000 for eligible Myeloma patients Myeloma Education Series Upcoming and archived education programs for patients, families, and healthcare professionals No one should fight cancer alone. More > Myeloma Education Program Understanding Myeloma Diagnosis and Treatment featuring  G. , MD associate professor of medicine, Dana-Farber Cancer Institute, Boston, MA. Listen to audio, read the transcript and view slides. Additional Information Information Resource Center  Support & Services  Clinical Trials Free Materials The Myeloma Guide. Information for Patients and Caregivers   Myeloma  Myeloma Facts & Statistics    Waldenstrom Macroglobulinemia      More Materials Join The Discussion Bulletin Boards Subscribe to one of LLS's Monthly Newsletters Name: Email: Zip/Postal Code: eNewsline LeukemiaLinks LymphomaLinks MyelomaLinks Hematologic Cancer News  LLS News   .. The whole immunoglobulin is composed of two larger pieces (heavy chains) and two smaller pieces (light chains) attached to each other. The Bence protein (light chains) made by M protein are small enough to pass through the kidney and enter the urine, where they can be detected. When excreted in large amounts, Bence protein can cause renal injury and kidney failure. There is a newer, special test to check for light chains. This test is called " serum-free light chains. "  Imaging tests include x-rays of areas of bone pain, x-rays of the skull, spine and ribs (skeletal survey), CT scans, MRIs and PET scans. X-rays and CT scans are used to see if there are any holes, breaks or thinning of the bones. MRIs and PET scans look for changes to the marrow and pockets of myeloma cells. A test called FISH (fluorescence in situ hybridization) is used to see if there are changes to the chromosomes of the myeloma cells. Lab and imaging tests are done to stage (measure the extent) of a patient's myeloma. Doctors determine the stage of the myeloma to help them decide which treatment approach to take. For decades, a staging system called the " Durie-Salmon System " has been used. This system measures the patient's blood hemoglobin concentration, the amount of M protein in blood and urine, the level of blood calcium, the level of kidney function, and the presence of bone lesions on imaging studies. A newer and more accurate method, called the " International Staging System, " relies on the degree of increase in the beta 2-microglobulin and the degree of decrease in serum albumin to determine disease stage. To determine the stage of the disease, the doctor checks: Blood counts of red or white cells. These may be lower than normal with myeloma. The amount of M protein found in blood and urine. M protein is made by the myeloma cells. The calcium level in the blood. This may be higher than normal with myeloma. The beta 2-microglobulin level in the blood. This may be higher than normal with myeloma. Beta 2-microglobulin is a protein found on the surface of plasma cells and some other cells. The albumin (a protein in the blood) level, which may be lower than normal in myeloma patients. How many parts of the bones the myeloma has affected. Return to top Disease Complications Myeloma patients may have problems with Infections. Myeloma patients may have more infections. This is because myeloma cells do not make antibodies to fight infection. Patients should follow the doctor's advice about how to reduce their risk. The doctor may give antibiotics to treat infections. Bone pain. Myeloma may cause bone pain. Drugs called bisphosphonates (Aredia® or Zometa®) may help. Bisphosphonates work by blocking the myeloma cells from making the bones weak. Kidney problems. Myeloma patients have a protein called light chains or Bence protein. Myeloma patients may also have high levels of calcium in their blood. Each of these can damage the kidneys. The doctor will check the patient's kidneys. Acute myelogenous leukemia (AML). A small number of myeloma patients develop AML. Return to top Treatment The goals of treatment for myeloma are to Slow the growth of the myeloma cells. Help patients who have bone pain, fatigue or other problems from their disease to feel better. Provide long periods of remission (when there are no signs of myeloma and/or the myeloma is not causing health problems). The treatment a patient receives depends on the type and stage of the myeloma and the patient's age and overall health. Most treatment plans include a combination of therapies. Some patients only need supportive care to reduce symptoms of anemia, high blood calcium levels, infections and/or bone damage. Others receive myeloma-specific therapies to treat disease progression and provide remissions. Myeloma-specific therapies include Single or combination drug therapy. High-dose chemotherapy with one of three types of stem cell transplant Autologous Allogeneic (as part of clinical trials) Reduced-intensity allogeneic Radiation therapy for local disease New and emerging drug therapies (as part of clinical trials) Drug Therapy. Drug therapy is the main treatment for myeloma. Before drug therapy begins, patients with symptomatic myeloma are assessed to determine if they are candidates for stem cell transplant. For transplant candidates, drug treatment begins with induction agents that do not cause bone marrow damage, for example, thalidomide (Thalomid®) and dexamethasone, bortezomib (Velcade®) and dexamethasone, or Velcade, pegylated liposomal doxorubicin (Doxil®) and dexamethasone. For patients who are not candidates for transplant, treatment may begin with a combination drug therapy, such as melphalan and prednisone, with Thalomid or Velcade. As many as six drugs are combined in some intensive treatment programs. Drug therapy has led to sustained remissions in some patients. Temporary cessation or significant slowing of the disease may occur for a time. Achieving complete remission for long periods is being seen more often as newer, more effective drugs are developed. Some Drugs Used To Treat Myeloma Bortezomib (Velcade®) is given by injection. It is approved by the FDA to treat people who have with myeloma (newly daignosed and previously treated patients). There are also a number of ongoing research studies (clinical trials) underway for Velcade. Thalidomide (Thalomid®) is given by mouth. Thalomid is used with dexamethasone to treat newly diagnosed myeloma patients. It is also being studied together with other drugs. Lenalidomide (Revlimid®) is a drug like Thalomid. Some studies have indicated that in comparison to Thalomid, Revlimid may be safer and work better for certain myeloma patients. Revlimid is used with dexamethasone to treat myeloma patients who have already had at least one other type of treatment. Melphalan (Alkeran®) is a type of chemotherapy used to treat some myeloma patients. Melphalan may be combined with other drugs such as Velcade, Thalomid or Revlimid. Stem Cell Transplantation. Autologous stem cell transplantation is an important therapy for many myeloma patients. This procedure uses the patient's own stem cells to restore blood cell production after intensive chemotherapy. Autologous transplant is associated with good response rates. It is relatively safe for many patients, including older patients. However, it is not appropriate for all patients and it is not a cure for myeloma. Patients should discuss the benefits and risks of transplantation with their physicians. Allogeneic stem cell transplantation and reduced-intensity allogeneic stem cell transplantation are being studied in clinical trials for myeloma. See the Clinical Trials section for more information. Radiation therapy. This treatment uses high-energy rays to kill myeloma cells. It is the main treatment for localized myeloma, such as solitary myeloma or plasmacytoma. Patients sometimes receive radiation therapy in preparation for stem cell transplantation. Carefully selected patients whose bone pain does not respond to chemotherapy may receive radiation therapy as well.  Return to top Clinical Trials Doctors are testing new drugs and new combinations of drugs to treat myeloma. " Clinical trials " are used to study new drugs, new treatments or new uses for approved drugs or treatments. A growing number of clinical trials include older adults. There are clinical trials for Newly diagnosed myeloma patients Patients who do not get a good response to treatment Patients who relapse after treatment Patients who continue treatment after remission (maintenance). Some clinical trials test new ways to use drugs that are already approved. For example, changing the amount of the drug or giving the drug along with another type of treatment might be better. The more people who take part in clinical trials, the faster we will find better ways to treat myeloma. You can also call the Information Resource Center for information about clinical trials; or use our free clinical trials service.   Stem Cell Transplants under Study in Clinical Trials. For myeloma patients, allogeneic stem cell transplants are used less often to treat myeloma than autologous stem cell transplants. With this type, stem cells from a donor are used. The donor can be a brother or sister. Or the donor can be another person with stem cells that " match " the patient's. It may be a good treatment for patients younger than age 55 who are not doing well with other treatments. For myeloma, allogeneic transplants are usually done as part of a clinical trial. Doctors are working to make allogeneic stem cell transplants safer. A type of transplant called a " reduced-intensity transplant " is under study. A reduced-intensity transplant uses lower doses of chemotherapy than a standard allogeneic stem cell transplant. This treatment is also called a " nonmyeloablative " transplant. Older and sicker patients may be helped by this treatment. Some patients may benefit from having two stem cell transplants. Studies are under way to see if it helps myeloma patients to have an autologous transplant and a reduced-intensity allogeneic stem cell transplant. Ask your doctor if participating in a clinical trial is right for you. For more information about clinical trials, you can view, print or order the free LLS booklet Understanding Clinical Trials for Blood Cancers. You can also watch the free LLS Web video My Clinical Trials Journey. Return to top Side Effects of Treatment Myeloma patients should talk with their doctors about side effects before they begin any type of treatment. Patients react to treatment in different ways. Sometimes there are very mild side effects. Other side effects may be serious and last a long time. Some side effects of myeloma treatment may include Upset stomach and vomiting Mouth sores Constipation Extreme tiredness Infections Low red cell count (anemia) Low white cell count Low platelet count Achy feeling Numb feeling in arms, hands, legs or feet. Return to top Response to Treatment Your doctor does tests to see if treatment is working. The test results help the doctor to decide if changes to treatment are needed. Blood and urine tests are done to check blood cell counts, kidney function and growth of myeloma cells. A bone marrow biopsy is used to look at the amount and pattern of myeloma cells in the marrow. Imaging tests (x-rays, CT scans, MRIs and PET scans) are used to look at the bones and marrow. X-rays and CT scans are used to see if there are any holes, breaks or thinning of the bones. MRIs and PET scans look for changes to the marrow and for pockets of myeloma cells. The doctor may use these terms to talk about a patient's response to treatment: Remission. No sign of disease Complete remission or response. No sign of M protein in the blood and urine. Normal percentage of plasma cells or no sign of myeloma cells in marrow Partial remission or response. More than a 50 percent decrease in M protein in the blood. Complete molecular remission or response. No sign of myeloma cells in the marrow using very sensitive tests. Minimal response. Less than a 50 percent decrease in M protein in the blood. Progressive disease. At least a 25 percent increase in M protein in the blood, new areas of bone damage or a new mass of myeloma cells. Return to top Get More Information The Leukemia & Lymphoma Society offers ongoing education programs featuring leading myeloma specialists discussing the latest issues in the diagnosis and treatment of myeloma. Visit the Myeloma Education Series page to find out about upcoming and archived programs. These programs are offered at no charge. Further details on treatment and supportive care may be obtained from The Leukemia & Lymphoma Society's free booklets The Myeloma Guide. Information for Patients and Caregivers and Myeloma. Visit the Myeloma Facts & Statistics page for more information on incidence and survival rates. Return to top Contact Us The Leukemia & Lymphoma Society Home Office 1311 Mamaroneck Ave. White Plains, NY 10605 or call the Information Resource Center at (800) 955-4572  Myeloma Facts & Statistics - An estimated 20,180 new cases of myeloma (11,170 men and 9,010 women) are expected to be diagnosed in the United States in 2010. An estimated 69,598 people are living with, or are in remission from, myeloma in the United States. back to top last updated on 12/16/10 The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. Need Help? Contact us by email, mail, or call (800) 955-4572 copyright | disclaimer | link | privacy | security var _hbEC=0,_hbE=new Array;function _hbEvent(a,{b=_hbE[_hbEC++]=new Object();b._N=a;b._C=0;return b;} var hbx=_hbEvent( " pv " );hbx.vpc= " HBX0103u " ;hbx.gn= " ehg-lls.hitbox.com " ; //BEGIN EDITABLE SECTION //CONFIGURATION VARIABLES hbx.acct= " DM530922E7VZ80EN3;DM53070222FD80EN3 " ;//ACCOUNT NUMBER(S) hbx.pn= " Myeloma " ;//PAGE NAME(S) hbx.mlc= " /LLS/Disease+Information " ;//MULTI-LEVEL CONTENT CATEGORY hbx.pndef= " title " ;//DEFAULT PAGE NAME hbx.ctdef= " full " ;//DEFAULT CONTENT CATEGORY //OPTIONAL PAGE VARIABLES //ACTION SETTINGS hbx.fv= " " ;//FORM VALIDATION MINIMUM ELEMENTS OR SUBMIT FUNCTION NAME hbx.lt= " auto " ;//LINK TRACKING hbx.dlf= " n " ;//DOWNLOAD FILTER hbx.dft= " n " ;//DOWNLOAD FILE NAMING hbx.elf= " n " ;//EXIT LINK FILTER //SEGMENTS AND FUNNELS hbx.seg= " 11 " ;//VISITOR SEGMENTATION hbx.fnl= " " ;//FUNNELS //CAMPAIGNS hbx.cmp= " " ;//CAMPAIGN ID hbx.cmpn= " " ;//CAMPAIGN ID IN QUERY hbx.dcmp= " " ;//DYNAMIC CAMPAIGN ID hbx.dcmpn= " " ;//DYNAMIC CAMPAIGN ID IN QUERY hbx.dcmpe= " " ;//DYNAMIC CAMPAIGN EXPIRATION hbx.dcmpre= " " ;//DYNAMIC CAMPAIGN RESPONSE EXPIRATION hbx.hra= " " ;//RESPONSE ATTRIBUTE hbx.hqsr= " " ;//RESPONSE ATTRIBUTE IN REFERRAL QUERY hbx.hqsp= " " ;//RESPONSE ATTRIBUTE IN QUERY hbx.hlt= " " ;//LEAD TRACKING hbx.hla= " " ;//LEAD ATTRIBUTE hbx.gp= " " ;//CAMPAIGN GOAL hbx.gpn= " " ;//CAMPAIGN GOAL IN QUERY hbx.hcn= " " ;//CONVERSION ATTRIBUTE hbx.hcv= " " ;//CONVERSION VALUE hbx.cp= " null " ;//LEGACY CAMPAIGN hbx.cpd= " " ;//CAMPAIGN DOMAIN //CUSTOM VARIABLES hbx.ci= " " ;//CUSTOMER ID hbx.hc1= " Home+Office " ;//CUSTOM 1 hbx.hc2= " Home+Office/Myeloma " ;//CUSTOM 2 hbx.hc3= " Myeloma/Home+Office " ;//CUSTOM 3 hbx.hc4= " LLS " ;//CUSTOM 4 hbx.hrf= " " ;//CUSTOM REFERRER hbx.pec= " " ;//ERROR CODES //INSERT CUSTOM EVENTS //END EDITABLE SECTION //REQUIRED SECTION. CHANGE " YOURSERVER " TO VALID LOCATION ON YOUR WEB SERVER (HTTPS IF FROM SECURE SERVER) From: onthewtr@... <onthewtr@...> Subject: Re: [ ] CML and Myeloma Date: Thursday, December 23, 2010, 11:02 PM  What is Myeloma? Are we talking abt melanoma? Sent via BlackBerry by AT & T [ ] CML and Myeloma  Hi all, I was diagnosed with CML back in 2000 and have been part of the 113 sti571 (Glivec/Gleevec) trial since january 2001. Today I was diagnosed with Myeloma, I am led to believe that this is a fairly rare occurrence, for someone to have CML and Myeloma at the same time. Novartis - the manufacturer's of Glivec/Gleevec - say that they have no statistical data related to people within the trial group who may have developed Myeloma. My question to the group is, does anyone have any knowledge of anyone who may have developed Myeloma in conjunction with CML while taking Glivec/Gleevec; or any other form of treatment? Any infornmation regarding this would be greatly appreciated. With regards Beau Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 24, 2010 Report Share Posted December 24, 2010 Hi All, Thank you all for your kind thoughts and words, it is much appreciated. Thanks Karine for that detailed info, that will aid me in answering a lot of my questions. I forgot to mention that I actually live in Australia, not the USA, but all the info is still relevant and appreciated. The Myeloma showed up because I have continued to have bone marrow testing done, even though Novartis has only been running trial testing on PB for the last two and a half years. From the 2009 test to the 2010 test - Para-protein (a marker for Myeloma) showed up in the bone marrow aspirate, I then had further blood tests, with the B cell test returning positive for Myeloma. So I'm hopeful that it has been discovered early in the development stage. Today, 24th December I had a skeletal scan done - which is series of x-rays of all your long bones, head, torso and spine, this is done to look for lesions on the bones as Myeloma effects the integrity of your bones. On the 6th of January I will have a BMA done and it will be cultured for cytogenetic testing, just like early stage CML, looking for chromosomal abnormalities. It all feels a bit weird, being back at the start of something like this, after having CCR for CML for six years. I was just happily cruising along and life had a very normal rhythm to it, now that all feels a little out of kilter. I am grateful to have a place such as this to be able to express, out loud some of the things that are rolling around in my head. I haven't post on many occasions over the years, but I have read the posting from this site and its preceding one over the past ten years, and have always found them a source of comfort and inspiration. So, I thank you all for your caring and comfort that you have offered me at this time. It is now Christmas morning (early) here, where I live, so I wish you all a joyous and safe time. With Kindest Regards Beau _____ I am using the Free version of SPAMfighter <http://www.spamfighter.com/len> .. SPAMfighter has removed 92 of my spam emails to date. Do you have a slow PC? <http://www.spamfighter.com/SLOW-PCfighter?cid=sigen> Try free scan! Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 25, 2010 Report Share Posted December 25, 2010 Beau, So happy to be able to give you some information that may help you! Good luck to you and have a Merry Christmas! From: worlord <worlord@...> Subject: [ ] Re: CML and Myeloma Date: Friday, December 24, 2010, 9:30 AM  Hi All, Thank you all for your kind thoughts and words, it is much appreciated. Thanks Karine for that detailed info, that will aid me in answering a lot of my questions. I forgot to mention that I actually live in Australia, not the USA, but all the info is still relevant and appreciated. The Myeloma showed up because I have continued to have bone marrow testing done, even though Novartis has only been running trial testing on PB for the last two and a half years. From the 2009 test to the 2010 test - Para-protein (a marker for Myeloma) showed up in the bone marrow aspirate, I then had further blood tests, with the B cell test returning positive for Myeloma. So I'm hopeful that it has been discovered early in the development stage. Today, 24th December I had a skeletal scan done - which is series of x-rays of all your long bones, head, torso and spine, this is done to look for lesions on the bones as Myeloma effects the integrity of your bones. On the 6th of January I will have a BMA done and it will be cultured for cytogenetic testing, just like early stage CML, looking for chromosomal abnormalities. It all feels a bit weird, being back at the start of something like this, after having CCR for CML for six years. I was just happily cruising along and life had a very normal rhythm to it, now that all feels a little out of kilter. I am grateful to have a place such as this to be able to express, out loud some of the things that are rolling around in my head. I haven't post on many occasions over the years, but I have read the posting from this site and its preceding one over the past ten years, and have always found them a source of comfort and inspiration. So, I thank you all for your caring and comfort that you have offered me at this time. It is now Christmas morning (early) here, where I live, so I wish you all a joyous and safe time. With Kindest Regards Beau _____ I am using the Free version of SPAMfighter <http://www.spamfighter.com/len> .. SPAMfighter has removed 92 of my spam emails to date. Do you have a slow PC? <http://www.spamfighter.com/SLOW-PCfighter?cid=sigen> Try free scan! Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.